Search

Search Results

• Advancement level of mobile applications intended for type 1 diabetes therapy supporting

  Tomasz Jerzy Nowicki, Grzegorz Józef Nowicki, Barbara Ślusarska

  704-713

  2020-09-26
• The range of possible chromium III applications in medicine - the short review

  Patrycja Wiśniewska, Izabela Czyżewska, Piotr M. Jarosz

  286-290

  2020-08-18
• Pathophysiological association of expression hormone of adipose tissue omentin-1 and the degree of vascular remodeling of brachyocephalic vessels in persons with obesity and disorders of carbohydrate metabolism

  Roman Leonidovich Kulynych, Olena Anatolyevna Soloviuk, Oleksandr Olegovich Soloviuk

  127-143

  2020-10-30
• Metformin as a medicine decreasing cardiovascular risk in patients suffering from type 2 diabetes mellitus

  Małgorzata Wieteska, Agnieszka Kaczyńska, Dominik Maj, Paweł Stanicki, Aleksandra Chałupnik, Piotr Wójcik

  105-111

  2020-08-04
• Insulin resistance: from the source of development to clinical consequences

  Waldemar Pluta, Wioleta Dudzińska, Anna Lubkowska

  148-160

  2020-07-21
• Evaluation of effort tolerance in diabetic and non-diabetic patients undergoing cardiac rehabilitation after cardiac surgery

  Aleksandra Szylińska, Alicja Mińko, Zuzanna Hilicka, Dominik Turzyński, Jakub Udzik, Piotr Sulikowski, Izabela Grabińska, Iwona Rotter

  383-392

  2020-08-28
• Association of glycation markers with the progression of the initial stages of diabetic non-proliferative retinopathy in type 2 diabetes mellitus

  Konstantin Korobov

  97-112

  2021-03-30
• The influence of intestinal microbiota on the development of type 1 diabetes

  Katarzyna Augustowska, Agnieszka Protasiuk, Rafał Sierzpowski, Patrycja Tymoszuk, Agata Żak

  56167

  2024-11-27
• Pancreatic Islet Transplantation in Patients suffering from Type 1 diabetes - Indications, methods, possible risks and future directions: A literature review

  Marta Wolanin, Bartłomiej Stachyra, Cezary Stawikowski, Bartłomiej Zielonka, Aleksandra Osińska, Izabela Wolanin, Karolina Madej; Barbara Dengler, Ilona Kowalczyk, Paulina Krawiec

  47-63

  2023-05-21
• Assess the knowledge level of POZ patients on the diagnosis and treatment of type 2 diabetes

  Małgorzata Żebrowska, Edyta Medak, Małgorzata Pachuta, Magdalena Brodowicz-Król

  338-356

  2017-07-19
• Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients

  G. Mykhalchyshyn

  254-260

  2020-11-30
• The role of selected mechanisms of innate immunity in the pathogenesis of diabetes

  Paulina Trojanowska, Magdalena Chrościńska-Krawczyk, Alina Trojanowska, Ewa Tywanek, Jakub Wronecki, Robert Jan Łuczyk

  544-549

  2021-09-27
• Plant based diet and cardio-metabolic disease

  Justyna Dąbrowska, Magdalena Wójcik, Joanna Borowik, Kinga Kuśmierczuk, Halina Pieciewicz-Szczęsna

  149-157

  2020-05-25
• The clinically relevant diabetic foot syndrome morphology

  V. Polyovyy, Bilel Khorshani, R. Sydorchuk, P. Kyfiak, O. Khomko, I. Plehutsa

  262-274

  2021-05-28
• Predictors of NAFLD rapidly progression in type 2 diabetes patients

  G. Mykhalchyshyn

  230-236

  2020-10-30
• Стоматологический статус и биохимические показатели ротовой жидкости при сахарном диабете II типа = Dental status and biochemical indicators in oral liquid type II diabetes

  Alexandra Skiba, Oksana Denga, Olga Makarenko

  493-502

  2015-12-28
• Modern views on diabetes mellitus in individuals after cholecystectomy as a prerequisite for the substantiation and development of a physical rehabilitation program

  Nataliya Golod

  315-334

  2017-10-30
• Oncological pathology in type 2 diabetes patients and its effects on the effectiveness of the treatment of diabetes

  Z. G. Krushinska, T. Yu. Yuzvenko

  337-348

  2019-11-29
• The bidirectional relationship between depression and diabetes

  Zuzanna Chilimoniuk, Maciej Dobosz, Aleksandra Chałupnik, Aleksandra Borkowska, Grzegorz Mizerski

  67-77

  2022-03-15
• Studying fatty acid content in red blood cell membranes in diabetic retinopathy of type 2 diabetes patients

  Mykhailo Bykhovets

  51-60

  2020-10-15
• Omnipod® Insulin Management System - "patch-pump", as a breakthrough in the treatment of type 1 diabetes

  Joanna Filipczak, Przemysław Żelazny, Oliwer Sygacz, Sebastian Bróż, Sara Dankiewicz, Aleksandra Swora, Joanna Borowik, Wojciech Brodowski, Piotr Pawłowski, Katarzyna Basta-Arciszewska, Karolina Obuchowska

  583-590

  2022-09-08
• The influence of the ketogenic diet on the therapy of type 2 diabetes. A literature review

  Aleksandra Madej, Hanna Senat, Patrycja Grabowska, Patrycja Bolla, Aleksandra Senat, Zuzanna Marczyńska, Mateusz Dorochowicz

  112-124

  2024-02-04
• The role of the gut microbiota in the pathogenesis and therapy of type 2 diabetes mellitus

  Aleksandra Madej, Hanna Senat, Patrycja Grabowska, Patrycja Bolla, Aleksandra Senat, Zuzanna Marczyńska, Anna Niemczyk, Mateusz Dorochowicz

  38-51

  2024-01-22
• The impact of new glucose monitoring systems on parameters of diabetes metabolic control. Literature review

  Weronika Salasa, Tomasz Seredyński, Wojciech Mądry, Aleksandra Mazurkiewicz, Magdalena Kołodziej, Joanna Męczyńska, Nazarii Saiuk, Michał Andrzej Kozicz, Adriana Wojciechowska, Justyna Marcicka

  50885

  2024-05-10
• Role of ketogenic and low-carbohydrate diets in the pathogenesis and treatment of obesity and diabetes mellitus type 1 and 2 - A Literature Review

  Dominika Bąk, Julia Buszek, Piotr Czerniak, Adrianna Antoszewska, Weronika Bargiel, Halszka Wajdowicz, Mateusz Warzocha, Aldona Sokołowska

  60329

  2025-06-16
• Euglycemic diabetes ketoacidosis associated with SGLT-2 inhibitors - review of case reports

  Joanna Winciorek, Piotr Cyran, Anna Jaroszyńska, Filip Jaroszyński, Joanna Kowal, Jan Paleczny, Robert Parobczak, Paweł Jakub Połujański, Adrianna Marta Wiśniewska

  55325

  2024-09-24
• Clinical and psychopathological features of patients with type II diabetes mellitus

  A. Kondratenko

  182-187

  2021-11-30
• Assessment of white blood cell distribution as a prognostic factor in type 2 diabetes mellitus and its complications - literature overview

  Joanna Szydełko, Magdalena Szydełko, Agnieszka Szymczyk, Monika Podhorecka

  713-722

  2018-08-16
• Lipids profile and thyroid parameters in patients with type 2 diabetes mellitus

  T. Yuzvenko

  227-232

  2016-03-31
• Attitude of patients with type 2 diabetes towards the disease versus chosen sociodemographic and medical factors – psychometric properties of the DAS-3 scale in the Polish version

  Cecylia Olszak, Elżbieta Nowicka, Bożena Baczewska, Robert Jan Łuczyk, Beata Kropornicka, Ewa Krzyżanowska, Jadwiga Daniluk

  248-261

  2017-12-22
• The Impact of Apple Cider Vinegar on Insulin Resistance and Related Conditions: Benefits, Mechanisms, and Potential Risks - Literature Review

  Sabina Kadłubek, Magdalena Mąka, Szymon Kalinowski, Julia Woźniak, Natalia Kapturska, Kinga Cymerys, Piotr Kardaszewski, Jakub Kamiński, Dominik Sikora, Martyna Zielnik

  56408

  2024-12-08
• Intestinal microbiota and obesity

  Patrycja Zuziak, Natalia Ilnicka, Leila Abod, Daria Matyja, Maria Sadlik

  142-148

  2022-12-26
• Taking care of a patient with type 2 diabetes as part of visiting nurse’s work

  Adrianna Grzegorczyk, Aleksandra Radomska, Ewa Kupcewicz

  1018-1036

  2019-09-19
• Влияние нарушений мочеиспускания на качество жизни при урогенитальной форме диабетической автономной нейропатии у пациенток с сахарным диабетом 1 и 2 типов = Influence of urination disorders on quality of life in the urogenital form of diabetic autonomic neuropathy in patients with diabetes mellitus type 1 and 2

  N. A. Kravchun, E. Y. Tkachuk, V. V. Shuhtin, V. S. Goydyk

  682-690

  2016-09-30
• Intermittent fasting - a diet to fight type 2 diabetes and obesity - current state of knowledge

  Joanna Mazurek, Hubert Stachowicz, Monika Adamczyk, Aleksandra Baran, Weronika Bartos, Magdalena Ptasznik, Magdalena Piotrowska-Żołnierczuk, Miłosz Podrażka, Justyna Lenart, Ewelina Flegiel

  55044

  2024-09-12
• Vitamin D deficiency in obese patients with Type 2 diabetes

  Aneta Szafraniec, Dominik Porada, Beata Matyjaszek-Matuszek

  1548-1554

  2018-09-15
• Пародонтопротекторное действие антидисбиотических средств при экспериментальном сахарном диабете 2 типа = Periodontitis-protective effecr of anti-dysbiotic means at experimental diabetes mellitus type 2

  E. P. Stupak, K. V. Skidan, M. I. Skidan, S. A. Dem'yanenko

  588-597

  2015-12-31
• Peculiarities of the formation of exocrine pancreatic insufficiency in patients with primary osteoarthritis under conditions of comorbidity

  Iryna Halabitska

  125-134

  2023-11-05
• Assessment of the level of acceptance of the illness and of satisfaction with life in patients with type 2 Diabetes aged 45-60

  Ewelina Bąk, Magdalena Kunc-Małyjurek

  34-50

  2018-06-23
• SGLT2 inhibitors in preventing progression of chronic kidney disease in patients with type 2 diabetes: a literature review

  Michał Szczepański, Marcin Kuliga, Mateusz Bajak, Julia Słowik, Julia Inglot, Jadwiga Inglot, Dominik Maciej Feret, Daniel Zapasek, Maciej Mamczur, Damian Sowa

  56369

  2024-12-08
• Potential anti-cancer features of metformin

  Aleksandra Puła, Urszula Krzysiek, Klaudia Podgórska, Kamila Gorczyca, Klaudia Artykiewicz, Aleksandra Słupczyńska, Weronika Urbaś, Marcin Czarkowski, Paweł Kozieł, Maria Grodkiewicz

  136-145

  2022-11-28
• Sodium-glucose co-transporter 2 inhibitors – a review article

  Marcin Makuch, Marcelina Makuch, Ewa Krzewicka-Romaniuk, Grzegorz Dzida

  42-49

  2019-08-20
• The value of polymorphism RRO12ALA gene PPARG in violation of lipid peroxidation and antioxidant protection in patients with type 2 diabetes mellitus

  S. V. Ziablytsev, V. Y. Mokrii, M. V. Crystal

  626-636

  2016-09-29
• Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus

  Mirella Czapska, Kamila Babkiewicz, Szczepan Pabis, Katarzyna Skórzyńska-Dziduszko

  335-351

  2018-12-14
• Single nucleotide polymorphisms in adiponectin and its receptors’ genes as potential risk factors for coronary artery disease in type 2 diabetes mellitus – an up-to-date overview

  Joanna Szydełko, Izabela Dąbrowska

  722-734

  2021-09-28
• Pioglitazone - the forgotten drug with multidirectional action

  Arkadiusz Aab, Julia Zarańska

  11-19

  2023-04-25
• Nursing care of 80 years-old patient with type 2 diabetes at home

  Bogusława Ryś, Kamila Górna, Ewelina Bąk, Julia Kostka

  54799

  2024-09-01
• Role of vegan and vegetarian diets in type 2 diabetes

  Dagna Siedlecka, Wojciech Micał, Ewa Krzewicka-Romaniuk, Anna Pradiuch

  344-348

  2019-07-20
• Teplizumab - current state of knowledge on the effects of teplizumab in preventing the development of type 1 diabetes in people at risk

  Justyna Białek, Karolina Nitka, Marta Więckowska-Deroń, Monika Leszcz, Dominika Ćwik-Błotnicka, Joanna Borczyk, Martyna Lewkowicz

  288-299

  2023-08-18
• Ketogenic diet as a tool in the treatment of diseases

  Natalia Ilnicka, Leila Abod, Daria Matyja, Maria Sadlik, Patrycja Zuziak

  199-203

  2022-11-18
• Wpływ wybranych czynników społeczno-demograficznych i medycznych na akceptację choroby w grupie osób z cukrzycą typu 2 = The influence of selected socio-demographic and medical factors on the acceptance of illness in a group of patients with type 2 diabetes mellitus

  Cecylia Olszak, Elżbieta Nowicka, Bożena Baczewska, Robert Łuczyk, Beata Kropornicka, Ewa Krzyżanowska, Jadwiga Daniluk

  11-28

  2016-12-01
• Optimization of treatment of patients with ischemic heart disease after suffering intervention in the coronary arteries

  Y. I. Karpenko, O. V. Blikhar

  560-566

  2016-08-26
• A case of a patient with type 1 diabetes mellitus and anorexia nervosa with changes to the central nervous system

  Armand Bajaka

  139-145

  2024-02-24
• Icodec insulin - revolution in diabetes type 2 insulin therapy

  Michał Dobrzyński, Jakub Czarnota, Tomasz Skubel, Małgorzata Drozd, Iga Dudek, Natalia Rybak

  1136-1142

  2022-08-25
• Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review

  Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

  57712

  2025-02-06
• Therapeutic effects of creatine supplementation in patients with type II diabetes

  Aleksander Oskroba, Mateusz Pawlina, Aleksandra Orzechowska, Karolina Ziętara, Natalia Pawełczak, Karolina Raksa, Bartłomiej Zielonka, Ilona Kowalczyk, Piotr Pawłowski, Cezary Stawikowski

  68-73

  2023-03-24
• The psychological and emotional state of patients with type 2 diabetes mellitus on the background of excessive body weight

  V. I. Velichko, V. I. Nikitina, E. V. Said, A. Yu. Amirova

  531-539

  2017-03-23
• Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes

  Marcin Czarkowski, Karolina Raksa, Ewelina Powroźniak, Karol Spozowski

  319-327

  2022-09-01
• Этиопатогенетические, психопатогенетические и клинические аспекты когнитивных нарушений при сахарном диабете 2-го типа = Etiopathogenic, psychopathogenetic and clinical aspects of cognitive disorders in type 2 diabetes

  O. V. Tkachenko

  279-288

  2015-11-19
• Effects of berberine administration on insulin resistance, lipid profile and general health - Narrative Review

  Julia Piotrowska, Antonina Teresa Witkowska, Adrianna Domańska, Aleksandra Łubińska-Kowalska, Agata Żak-Gontarz, Aleksandra Minda, Adrianna Witkowska, Barbara Anna Zapalska, Justyna Janikowska, Krzysztof Julian Długosz, Monika Wendland

  60324

  2025-06-03
• Glucose Monitoring Systems - general rules of use and chances in therapy of type 1 diabetes

  Michał Garstka, Anna Gadomska, Justyna Kurek, Rafał Gorzyński, Hanna Dominik, Zuzanna Czudy, Wojciech Pawęska, Justyna Molczyk-Sieńczak, Jan Radwański, Marika Polatowska

  99-110

  2023-07-25
• Adapting to the therapeutic recommendations of patients treated of type 2 diabetes

  Natalia Alicja Świątoniowska, Beata Jankowska-Polańska

  542-562

  2017-04-20
• Ketogenic diet and metabolic health: A review of its impact on type 2 diabetes and obesity. Analysis of research on the ketogenic diet in the context of treating metabolic disorders

  Paweł Nojek, Monika Zawół, Mariusz Zimonczyk, Wiktoria Pawlik, Agnieszka Nowotarska, Gustaw Błaszczyński

  55923

  2024-11-19
• The ketogenic diet in the treatment of diabetes type 2

  Karolina Raksa, Mateusz Pawlina, Karolina Ziętara, Martyna Lewkowicz, Katarzyna Nowakowska, Przemysław Raczkiewicz

  92-98

  2022-05-14
• Profilaktyka cukrzycy typu 2 w grupie osób starszych = Type 2 diabetes prevention among elderly people

  Anna Mirczak

  109-122

  2016-12-03
• Роль метаболических нарушений в формировании когнитивной дисфункции при сахарном диабете 2 типа = Role of metabolic disorders in the formation of cognitive dysfunction in type 2 diabetes mellitus

  O. L. Tovazhnyanska, I. O. Bezuglova

  284-295

  2016-08-20
• Diabetes mellitus and its skin manifestations - dermatology for diabetologists

  Maria Sambura, Sara Rosołowska-Żak, Julia Pałuchowska, Anna Szymkowicz, Patrycja Paschke, Igor Miczek

  129-142

  2024-02-21
• Factors associated with adherence in patients with type 2 diabetes mellitus

  Natalia Świątoniowska, Krzysztof Dudek, Anna Szymczyk, Beata Jankowska-Polańska

  192-209

  2018-12-14
• Plant Based Diets and the Risk of Type 2 Diabetes

  Martyna Rozenbajgier, Justyna Wójcik-Grudzień, Paulina Pawłowska, Alicja Ozga-Stachurska

  439-445

  2022-09-04
• GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care

  Agnieszka Parfianowicz, Alicja Surma

  57478

  2025-02-04
• Obesity, type 2 diabetes and hormone replacement therapy vs. colorectal tumors in the elderly

  Małgorzata Szamocka, Monika Anna Ameryk, Agnieszka Meder, Alina Sokup, Maciej Świątkowski

  230-243

  2017-06-15
• How does the consumption of processed food affect the pathogenesis of various diseases? - literature review

  Paweł Smuszkiewicz-Różański, Gabriela Różańska-Smuszkiewicz, Karolina Koszyczarek, Maja Kotowska, Wiktoria Zamirska, Albin Ziemiański, Katarzyna Zięba, Anna Zygmunt

  109-128

  2024-02-19
• The role of the IRS1 gene (rs2943640) in the comorbid course of type 2 diabetes mellitus, obesity and arterial hypertension

  I. Vivsiana, H. Habor, M. Marushchak

  388-399

  2021-01-29
• Life orientation and chosen sociomedical indicators of women suffering from type 2 diabetes

  Cecylia Olszak, Elżbieta Nowicka, Bożena Baczewska, Beata Kropornicka, Robert Jan Łuczyk, Ewa Krzyżanowska, Anna Mróz, Agnieszka Zwolak, Jadwiga Daniluk

  490-507

  2018-12-23
• The content of resistin in the blood plasma and the activity of non-specific inflammation in patients with type 2 diabetes, depending on body weight and gender

  Alina Urbanovych

  68-77

  2015-11-06
• The Potential Role of Creatine Supplementation in Glycemic Control and Insulin Resistance: A Literature Review

  Klaudia Królikowska, Jakub Sikora, Karolina Knychalska, Mikołaj Łabuda, Aleksandra Słojewska, Agata Kotkowiak, Teresa Sowińska, Oliwia Mentel, Adrianna Bogucka, Agnieszka Szema

  59992

  2025-05-09
• Exploring the Impact of Intermittent Fasting on Metabolic Syndrome, Prediabetes and Type 2 Diabetes: a systematic review

  Karolina Kosieradzka, Katarzyna Kosecka, Patryk Rudziński, Aleksandra Cieślik, Dominik Adamowicz, Justyna Stańczyk, Inga Łopuszyńska, Astrik Meliksetian, Alicja Wosińska, Anna Jargieło

  111-125

  2023-07-25
• Tirzepatide – a new hope for type 2 diabetes mellitus and obesity management. A literature review.

  Izabela Stawicka, Izabela Orzołek, Jakub Jarmołowicz, Agata Boczar, Patryk Dryja

  55971

  2024-11-12
• The knowledge of Tarnobrzeg residents on diabetes type II and the educational needs - preliminary

  Aneta Jadach

  1405-1419

  2018-09-24
• Are metabolic disorders part of a severe mental illness? Historical and current perspective

  Urszula Lopuszanska

  102-115

  2020-11-03
• 

  Polygenic diseases

  Sergey Dolomatov, Walery Zukow, Anna Zhukova, Svetlana Smirnova

  58225

  2025-01-25
• Ketogenic diet - a literature review

  Iwona Cuber, Artur Aghadi, Edyta Białowąs, Ewelina Dybała, Magdalena Mazurek, Marta Górna

  132-141

  2023-02-20
• Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus

  T. Yu. Poniatowskaya

  55-61

  2015-03-20
• The prevalence of orthorexia nervosa in patients with selected chronic diseases

  Łukasz Ciulkiewicz, Patrycja Figurowska, Natalia Małek, Anita Kwiatkowska, Patryk Pluta, Konrad Karłowicz, Aleksandra Brożyna, Sara Emerla, Maria Hermanowska, Julia Lubomirska, Arkadiusz Bydliński, Michał Obrębski

  51236

  2024-05-29
• Ultrasound therapy of diabetes mellitus type 2

  I. Samosiuk, S. Zubkova, E. Chuhraeva, N. Samosiuk, W. Zukow

  68-74

  2011-02-20
• Особенности осморегулирующей функции почек у больных с сахарным диабетом 1 типа = Features of the renal osmoregulatory function in patients with type 1 diabetes

  E. S. Kuznetsova, E. N. Kuznetsova, V. V. Shuhtin, A. I. Gozhenko

  64-72

  2015-08-06
• The role of physical activity in type 1 diabetes: a review of the literature

  Monika Gaszyńska, Antonina Drzewiecka, Artur Drzewiecki, Wiktor Korczak, Maria Anna Madejska, Aleksandra Rudzka, Wojciech Falkowski, Anna Krysińska, Weronika Woźniak, Jakub Magielski

  59766

  2025-05-09
• Sleep duration and cardiovascular outcomes

  Martyna Lichman, Jakub Przeradzki, Aleksandra Borycka, Barbara Jędrzejewska, Maria Kotulska, Paulina Laskus, Zuzanna Lubczyńska, Zofia Potocka, Katarzyna Rząd, Julia Kochanowska

  17-34

  2023-05-16
• Adverse effects of GLP – 1 Receptor Agonists

  Anna Kasprzak, Monika Kułaga, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Borys Łozowski, Małgorzata Kasprzak, Barbara Wilczyńska

  57774

  2025-02-11
• Eating disorders in children and adolescents with type 1 diabetes mellitus

  Małgorzata Piekarska, Radosław Kasperski, Agata Pikulicka, Katarzyna Pacek, Klaudia Jedlina, Izabela Szulc, Weronika Swacha, Artur Aghadi, Martyna Janczewska, Izabela Kamińska

  337-343

  2023-02-15
• Berberine in the treatment of type 2 diabetes - literature review

  Aleksandra Mazurek, Mateusz Pawlicki, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Greguła, Aleksandra Kłos, Wiktoria Wilanowska

  49000

  2024-05-13
• The endothelial dysfunction factors in diabetes mellitus 2 type

  O. P. Chernobryvtsev

  410-416

  2019-01-31
• The influence of the Mediterranean diet on glucose metabolism

  Katarzyna Mielniczek

  430-433

  2021-09-22
• Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment

  Hanna Sitarek, Adrianna Tabeau, Joanna Prus, Justyna Pięta, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Marcel Chudzikowski, Agata Prokopiuk

  59642

  2025-05-06
• The use of SGLT2 inhibitors in the treatment of cognitive disorders

  Marta Lato, Konrad Iberszer, Maria Litwiniuk, Marcin Zaniuk, Kamil Hurkała, Dominika Antonik, Barbara Denys, Karolina Góra, Wojciech Zdziennicki, Patryk Zimnicki

  27-39

  2023-05-02
• Analysis of asthenic phenomens in patients with type 2nd diabetes mellitus in the clinical and psychological aspect

  O. V. Tkachenko

  736-744

  2017-03-29